Parkinsn's Email List Message
Posting to the Parkinsn List is a benefit of Subscription
Cabaser - New drug for UK
UpJohn, with a skillful bit of timing, chose World Parkinson's day to
launch Cabaser onto the UK market. (Perhaps better knowm to us as
Cabergoline).
Cabaser's main claim to fame is that it has a long 'half life', so
that a one tablet per day uptake is possible. Other than that, Cabaser
is another Dopamine Agonist, to join the list which now includes:-
Bromocriptine (Parlodel)
Pergolide (Celanse, Permax)
Lisuride (Revanil)
Ropinirole (ReQuip)
Pramipexole
In a move which appears to be solely to limit the range of alternatives
and thus keep the price well up, I gather that Cabaser is not to be
released on the US Market, and in exchange, Pramipexole is not to be
released on the UK market. Maybe the conspiracy theorists are not so
far out!
--
Brian Collins <bjc@xxxxxxxxxxxxxxx>
Parkinsn's Archive Treasures Doctors, students, patients and caregivers find current Parkinson's information such as the Algorithm, Caregivers Handbook, and talks by respected Movement Disorder Specialists.
Mail converted by MHonArc
2.6.10
Site Hosting donated by He.net
&
Grant from The Parkinson Alliance
